ATRC

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Atricure Inc

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure's Isolator ® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure's AtriClip ® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide.
CEO
Employees
750
Headquarters

News

Sernova to enroll second cohort in trial of Cell Pouch System for type 1 diabetes
Nov 03, 2022 00:00am

Sernova announced today that it received approval for a protocol amendment in the trial of its Cell Pouch System for treating type 1 diabetes. London, Ontario-based Sernova designed its proprietary Cell Pouch System as an implantable and scalable medical device. It forms a natural environment in the body for the long-term survival and function of […]


Source:WTWH
Cardiovascular Systems posts mixed-bag Q1 results
Nov 03, 2022 00:00am

Cardiovascular Systems (NSDQ:CSII) today posted first-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. The St. Paul, Minnesota-based heart device maker reported losses of $10.6 million, or -27¢ per share, on sales of $59.67 million for the three months ended September 30 for a sales gain of 2.23% compared with Q1 […]


Source:WTWH
AtriCure Inc. PT Lowered to $52 at JPMorgan
Nov 02, 2022 12:23pm

https://www.investing.com/news/pro/atricure-inc-pt-lowered-to-52-at-jpmorgan-432SI-2929450


Source:Investing.com
AtriCure, Inc. (ATRC) Q3 2022 Earnings Call Transcript
Nov 02, 2022 01:31am

AtriCure, Inc. (NASDAQ:NASDAQ:ATRC) Q3 2022 Earnings Conference Call November 1, 2022 4:30 PM ET Company Participants Marissa Bych - Investor Relations Michael Carrel - President and Chief…


Source:Seeking Alpha
Keysight combines 5G and GNSS technology for advanced location services
Nov 02, 2022 00:00am

Keysight Technologies, Inc., a technology company that delivers advanced design and validation solutions to help accelerate innovation to connect and secure the world, announced that it is first to gain Global Certification Forum (GCF) validation of a 5G location-based services (LBS) Assisted Galileo (A-Galileo) test case by combining 5G new radio (NR) and global navigation…


Source:WTWH
Hatco Acquires Food Warming Equipment Co.
Nov 02, 2022 00:00am

Hatco Corporation, headquartered in Milwaukee, Wis., announced the purchase of Food Warming Equipment Company Inc. (FWE) on Oct. 31. FWE is a manufacturer specializing in heated holding cabinets, cook-and-hold ovens, smokers, refrigerated cabinets, transport carts and more, with locations in Crystal Lake, Illinois and Portland, Tenn. “Like Hatco, FWE has been serving its customers for…


Source:WTWH
High-surge-rated SMD TVS diodes boast small package size
Nov 02, 2022 00:00am

Littelfuse, Inc. announced the new SMTOAK2 TVS Diode Series. Many of today’s high-power, high surge rating TVS diodes are only available in axial leaded packages. The compact, 2 kA 8/20 μs rated, surface-mount package SMTOAK2 TVS Diode Series allows electronics designers to achieve a more robust transient voltage, overvoltage protection, and lightning protection system while […]


Source:WTWH
AtriCure Reports Third Quarter 2022 Financial Results
Nov 01, 2022 20:01pm

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced third quarter 2022 financial results. “We are proud to share another quarter of strong commercial execution across our business, with excellent EnCompass traction following our launch earlier this year, increasing EPi-Sense® revenue and accounts, and ongoing


Source:Business Wire
AtriCure to Announce Third Quarter 2022 Financial Results
Oct 11, 2022 12:00pm

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its third quarter 2022 financial results on Tuesday, November 1, 2022. AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on Tuesday, November 1, 2022, to discuss its third quarter 2022 financial results. To access the webcas


Source:Business Wire